Radioiodine ' s Benefit Absent in Low-Risk Thyroid Cancer Radioiodine ' s Benefit Absent in Low-Risk Thyroid Cancer
Routine radioiodine ablation had no incremental benefit in patients with low-risk, differentiated thyroid cancer after total thyroidectomy, results from a prospective, nonrandomized study suggest.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | Hematology | Study | Thyroid | Thyroid Cancer | Thyroidectomy